Bristol-Myers Squibb buy The Goldman Sachs Group, Inc.
Start price
30.10.23
/
50%
€48.25
Target price
30.10.24
€65.03
Performance (%)
2.53%
Price
01.10.24
€47.82
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr shows slight gains of 2.53%. Dividends of €1.65 are taken into consideration when calculating the performance. This prediction currently runs until 30.10.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bristol-Myers Squibb | 4.892% | 4.892% |
iShares Core DAX® | 1.164% | 1.549% |
iShares Nasdaq 100 | 0.118% | 0.969% |
iShares Nikkei 225® | 1.124% | -1.120% |
iShares S&P 500 | 0.479% | 1.068% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat